❌Con:Raisescost forconsumers🌎ID&E:Opportunityto designfor inclusionThoratec🌎ID&E:Impactsaffordability forunderservedpopulations🌎ID&E:Increasesaccess tolife-savingdevicesCon:Antitrustchallenges“CaseStudyMentioned”✅Pro:CreatescompetitiveadvantageJenaValve🌎ID&E:May reduceequitableaccess ifcosts riseCon: Canlimitinnovation (ifmonopolized)“Antitrust”Pro:Lowerslong-termcosts🌎ID&E:Risk of biasintechnologyadoptionID&E: Riskof bias intechnologyadoption✅Pro:Expandstreatmentoptions🌎ID&E:Could createglobaldisparitiesEdwardsLifesciences“CaseStudyMentioned”Pro:Promotesfasterdevelopment✅Pro:EncouragesefficiencyTAVR-ARdevice🌎ID&E:Regulatoryoversightprotectsfairness“Antitrust”✅Pro:DrivesinnovationID&E: Mayreduceequitableaccess ifcosts rise✅Pro:Promotesfasterdevelopment✅Pro:ImprovespatientoutcomesCon:ReducescompetitionID&E:Regulatoryoversightprotectsfairness❌Con:Stiflessmallercompetitors❌Con:Potential jobloss insmaller firmsID&E:Opportunityto designfor inclusionCon:Potential jobloss insmaller firmsID&E:ImpactsaffordabilityforunderservedpopulationsHeartWare❌Con:Antitrustchallenges❌Con: Canlimitinnovation (ifmonopolized)Pro:EncouragesefficiencyID&E:Increasesaccess tolife-savingdevices❌Con:ReducescompetitionPro:Drivesinnovation✅Pro:Lowerslong-termcostsPro:Createscompetitiveadvantage“Innovation”“Innovation”Con: StiflessmallercompetitorsID&E: CouldcreateglobaldisparitiesPro:ImprovespatientoutcomesCon:Raisescost forconsumersCon: Riskof marketmonopolyPro:Expandstreatmentoptions❌Con:Risk ofmarketmonopoly❌Con:Raisescost forconsumers🌎ID&E:Opportunityto designfor inclusionThoratec🌎ID&E:Impactsaffordability forunderservedpopulations🌎ID&E:Increasesaccess tolife-savingdevicesCon:Antitrustchallenges“CaseStudyMentioned”✅Pro:CreatescompetitiveadvantageJenaValve🌎ID&E:May reduceequitableaccess ifcosts riseCon: Canlimitinnovation (ifmonopolized)“Antitrust”Pro:Lowerslong-termcosts🌎ID&E:Risk of biasintechnologyadoptionID&E: Riskof bias intechnologyadoption✅Pro:Expandstreatmentoptions🌎ID&E:Could createglobaldisparitiesEdwardsLifesciences“CaseStudyMentioned”Pro:Promotesfasterdevelopment✅Pro:EncouragesefficiencyTAVR-ARdevice🌎ID&E:Regulatoryoversightprotectsfairness“Antitrust”✅Pro:DrivesinnovationID&E: Mayreduceequitableaccess ifcosts rise✅Pro:Promotesfasterdevelopment✅Pro:ImprovespatientoutcomesCon:ReducescompetitionID&E:Regulatoryoversightprotectsfairness❌Con:Stiflessmallercompetitors❌Con:Potential jobloss insmaller firmsID&E:Opportunityto designfor inclusionCon:Potential jobloss insmaller firmsID&E:ImpactsaffordabilityforunderservedpopulationsHeartWare❌Con:Antitrustchallenges❌Con: Canlimitinnovation (ifmonopolized)Pro:EncouragesefficiencyID&E:Increasesaccess tolife-savingdevices❌Con:ReducescompetitionPro:Drivesinnovation✅Pro:Lowerslong-termcostsPro:Createscompetitiveadvantage“Innovation”“Innovation”Con: StiflessmallercompetitorsID&E: CouldcreateglobaldisparitiesPro:ImprovespatientoutcomesCon:Raisescost forconsumersCon: Riskof marketmonopolyPro:Expandstreatmentoptions❌Con:Risk ofmarketmonopoly

Competitive Technology - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
  1. ❌Con: Raises cost for consumers
  2. 🌎ID&E: Opportunity to design for inclusion
  3. Thoratec
  4. 🌎ID&E:Impacts affordability for underserved populations
  5. 🌎ID&E: Increases access to life-saving devices
  6. Con: Antitrust challenges
  7. “Case Study Mentioned”
  8. ✅Pro: Creates competitive advantage
  9. JenaValve
  10. 🌎ID&E: May reduce equitable access if costs rise
  11. Con: Can limit innovation (if monopolized)
  12. “Antitrust”
  13. Pro: Lowers long-term costs
  14. 🌎ID&E: Risk of bias in technology adoption
  15. ID&E: Risk of bias in technology adoption
  16. ✅Pro: Expands treatment options
  17. 🌎ID&E: Could create global disparities
  18. Edwards Lifesciences
  19. “Case Study Mentioned”
  20. Pro: Promotes faster development
  21. ✅Pro: Encourages efficiency
  22. TAVR-AR device
  23. 🌎ID&E: Regulatory oversight protects fairness
  24. “Antitrust”
  25. ✅Pro: Drives innovation
  26. ID&E: May reduce equitable access if costs rise
  27. ✅Pro: Promotes faster development
  28. ✅Pro: Improves patient outcomes
  29. Con: Reduces competition
  30. ID&E: Regulatory oversight protects fairness
  31. ❌Con: Stifles smaller competitors
  32. ❌Con: Potential job loss in smaller firms
  33. ID&E: Opportunity to design for inclusion
  34. Con: Potential job loss in smaller firms
  35. ID&E:Impacts affordability for underserved populations
  36. HeartWare
  37. ❌Con: Antitrust challenges
  38. ❌Con: Can limit innovation (if monopolized)
  39. Pro: Encourages efficiency
  40. ID&E: Increases access to life-saving devices
  41. ❌Con: Reduces competition
  42. Pro: Drives innovation
  43. ✅Pro: Lowers long-term costs
  44. Pro: Creates competitive advantage
  45. “Innovation”
  46. “Innovation”
  47. Con: Stifles smaller competitors
  48. ID&E: Could create global disparities
  49. Pro: Improves patient outcomes
  50. Con: Raises cost for consumers
  51. Con: Risk of market monopoly
  52. Pro: Expands treatment options
  53. ❌Con: Risk of market monopoly